As the 21st-century rise of noncombustible nicotine products introduces less deleterious modes of nicotine use, some 20th-century frameworks for tobacco control have become outdated. In particular, uniform restrictions across tobacco and nicotine products risk causing harm if switching to lower-risk products would improve some consumers’ health, if at-risk population groups respond differently to a given… Read more »
Archives: Seminars
Bonus Summit Content: How can embracing smoking harm reduction accelerate an increase in smoking cessation in the population?
Sadly, Dr Cummings is unable to join the Summit in D.C., as he has been called as an expert witness. However, he kindly agreed to record his presentation, as he is keen to hear people’s thoughts on the initiative outlined in it. You can use the App to ask questions and to comment. In this… Read more »
Summit Closing Thoughts
END OF SUMMIT DRINK RECEPTION
Panel Discussion and Q&A: How will we know when – or if – we get things right?
CLOSING KEYNOTE: End goals and big questions
The trajectory and implementation of tobacco control measures have generally been smooth and noncontroversial. The public health community was primarily focused on how to substantially reduce and optimistically eliminate cigarette smoking. However, the introduction of a variety of non-combusted nicotine products has led to divisive opinions about their role and potential impact on public health. Unless some consensus… Read more »
Is this what success looks like? 50 years of smoking in a society where cigarettes have competed with snus and, more recently, nicotine pouches
In the 1970s, 40 per cent of the Norwegian adult population smoked daily. By 2025, the figure had decreased to 7 per cent, making it one of the lowest rates in Europe. Among young adults, the decline was even more pronounced, from around 40 per cent to less than 2 per cent. It seems reasonable… Read more »
Defining failure: Unforeseen market consequences of regulatory restrictions on non-combusted nicotine products
Federal and state policies, along with a lack of enforcement, have created a situation where large markets for vape and nicotine pouches in the US remain largely unregulated. This has spurred the development of products containing untested nicotine analogue compounds to circumvent FDA regulatory scrutiny and has fostered consumer mistrust of the entire category. Meanwhile,… Read more »
Nicotine pouches: Will they make a difference?
Nicotine pouches are the latest consumer nicotine product with the potential to compete with cigarettes. They offer advantages such as delivering sufficient nicotine, being discreet to use, having a safety profile similar to NRT, and being validated by their tobacco-based counterpart, snus, which is gradually replacing smoking in Sweden and Norway. However, they require far… Read more »
Taking a comparative perspective: comparing cigarette and e-cigarette flavor restrictions across countries
In a perfect world, regulation of nicotine and tobacco products would match the evidence and uncertainties we have about their relative risks. But the true global picture for these policies is quite different, not just for differences in population health or income levels. Many governments have moved to restrict ENDS products while not adequately addressing… Read more »
Recent Comments